After decades of convergence, the gender gap in employment outcomes has recently plateaued
in many rich countries, despite the fact that women have increased their investment in …

Chronic kidney disease (CKD) causes substantial global morbidity and increases cardiovascular
and all-cause mortality. Unlike other chronic diseases with established strategies for …

Evidence-informed decision making in clinical care and policy in nephrology is undermined
by trials that selectively report a large number of heterogeneous outcomes, many of which …

Outcomes reported in randomized controlled trials in peritoneal dialysis (PD) are diverse, are
measured inconsistently, and may not be important to patients, families, and clinicians. The …

Background Although warfarin is indicated to prevent ischemic strokes in most patients with
atrial fibrillation (AF), evidence supporting its use in hemodialysis patients is limited. Our aim …

We describe here the tyrosine kinase activity of human biliverdin reductase (BVR) and its
potential role in the insulin-signaling pathway. BVR is both a substrate for insulin receptor (IR) …

Rationale & Objective Individuals faced with decisions regarding kidney replacement therapy
options need information on how dialysis treatments might affect daily activities and quality …

Home dialysis modalities (home hemodialysis [HD] and peritoneal dialysis [PD]) are
associated with greater patient autonomy and treatment satisfaction compared with in-center …

There are an estimated 14,000 randomized trials published in chronic kidney disease. The
most frequently reported outcomes are biochemical endpoints, rather than clinical and patient…

Results Across 14 groups, 126 participants (81 patients, 45 caregivers), aged 18–84 (mean
54, SD 15) years, identified 56 outcomes. The ten highest ranked outcomes were PD …